Itraconazole in chronic cavitary pulmonary aspergillosis: A randomised controlled trial and systematic review of literature

Mycoses

Volumn 56, Issue 5, 2013, Pages 559-570

  Agarwal, Ritesh ^a   Vishwanath, Gella ^a   Aggarwal, Ashutosh N ^a   Garg, Mandeep ^a   Gupta, Dheeraj ^a   Chakrabarti, Arunaloke ^a  

^a POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Aspergilloma; Aspergillus; CCPA; Chronic pulmonary aspergillosis; CNPA

Indexed keywords

ANTIFUNGAL AGENT; DEXTROMETHORPHAN; FERROUS ASCORBATE; FOLIC ACID; FUNGITRACE; IRON; ITRACONAZOLE; MICAFUNGIN; PHENYLEPHRINE; POSACONAZOLE; TRIPROLIDINE; UNCLASSIFIED DRUG; VORICONAZOLE;

ADULT; ADVERSE OUTCOME; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; ASPERGILLUS; CHRONIC CAVITARY PULMONARY ASPERGILLOSIS; CLINICAL ARTICLE; CONTROLLED STUDY; COUGHING; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTRITIS; HEMOPTYSIS; HEPATITIS; HUMAN; HUMAN TISSUE; LUNG ASPERGILLOSIS; LUNG CAVITY; MALE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SAMPLE SIZE; SIDE EFFECT; SPUTUM ANALYSIS; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT RESPONSE;

ASPERGILLOMA; ASPERGILLUS; CCPA; CHRONIC PULMONARY ASPERGILLOSIS; CNPA;

ADULT; ANTIFUNGAL AGENTS; CHRONIC DISEASE; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FEMALE; HUMANS; ITRACONAZOLE; MALE; PROSPECTIVE STUDIES; PULMONARY ASPERGILLOSIS; RADIOGRAPHY, THORACIC; TREATMENT OUTCOME;

ASPERGILLUS;

EID: 84881022988     PISSN: 09337407     EISSN: 14390507     Source Type: Journal    
DOI: 10.1111/myc.12075     Document Type: Article

References (32)

1. Denning DW. Chronic forms of pulmonary aspergillosis. Clin Microbiol Infect 2001; 7(Suppl. 2): 25-31.
2. Denning DW, Riniotis K, Dobrashian R, Sambatakou H. Chronic cavitary and fibrosing pulmonary and pleural aspergillosis: case series, proposed nomenclature change, and review. Clin Infect Dis 2003; 37(Suppl. 3): S265-80.
3. Brik A, Salem AM, Kamal AR et al. Surgical outcome of pulmonary aspergilloma. Eur J Cardiothorac Surg 2008; 34: 882-5.
4. Riscili BP, Wood KL. Noninvasive pulmonary Aspergillus infections. Clin Chest Med 2009; 30: 315-35. vii.
5. Lee JG, Lee CY, Park IK et al. Pulmonary aspergilloma: analysis of prognosis in relation to symptoms and treatment. J Thorac Cardiovasc Surg 2009; 138: 820-5.
6. Denning DW, Pleuvry A, Cole DC. Global burden of chronic pulmonary aspergillosis as a sequel to pulmonary tuberculosis. Bull World Health Organ 2011; 89: 864-72.
7. Saraceno JL, Phelps DT, Ferro TJ, Futerfas R, Schwartz DB. Chronic necrotizing pulmonary aspergillosis: approach to management. Chest 1997; 112: 541-8.
8. British Thoracic and Tuberculosis Association. Aspergilloma and residual tuberculous cavities-the results of a resurvey. Tubercle 1970; 51: 227-45.
9. Walsh TJ, Anaissie EJ, Denning DW et al. Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 2008; 46: 327-60.
10. Jain LR, Denning DW. The efficacy and tolerability of voriconazole in the treatment of chronic cavitary pulmonary aspergillosis. J Infect 2006; 52: e133-7.
11. Camuset J, Nunes H, Dombret MC et al. Treatment of chronic pulmonary aspergillosis by voriconazole in nonimmunocompromised patients. Chest 2007; 131: 1435-41.
12. Dupont B. Itraconazole therapy in aspergillosis: study in 49 patients. J Am Acad Dermatol 1990; 23: 607-14.
13. De Beule K, De Doncker P, Cauwenbergh G et al. The treatment of aspergillosis and aspergilloma with itraconazole, clinical results of an open international study (1982-1987). Mycoses 1988; 31: 476-85.
14. Campbell JH, Winter JH, Richardson MD, Shankland GS, Banham SW. Treatment of pulmonary aspergilloma with itraconazole. Thorax 1991; 46: 839-41.
15. Lebeau B, Pelloux H, Pinel C et al. Itraconazole in the treatment of aspergillosis: a study of 16 cases. Mycoses 1994; 37: 171-9.
16. Guazzelli LS, Xavier MO, Oliveira FdM, Severo LC. Chronic cavitary pulmonary aspergillosis and fungal balls. In: Pasqualotto AC (ed.), Aspergillosis: From Diagnosis to Prevention. New York: Springer, 2009: 585-620.
17. Tsubura E. Multicenter clinical trial of itraconazole in the treatment of pulmonary aspergilloma. Pulmonary Aspergilloma Study Group. Kekkaku 1997; 72: 557-64.
18. Kohno S, Masaoka T, Yamaguchi H et al. A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan. Scand J Infect Dis 2004; 36: 372-9.
19. Sambatakou H, Dupont B, Lode H, Denning DW. Voriconazole treatment for subacute invasive and chronic pulmonary aspergillosis. Am J Med 2006; 119: 527. e17-24.
20. Hagiwara E, Sekine A, Sato T et al. Clinical features of chronic necrotizing pulmonary aspergillosis treated with voriconazole in patients with chronic respiratory disease. Nihon Kokyuki Gakkai Zasshi 2008; 46: 864-9.
21. Yasuda S, Ohnishi R, Suzuki T, Sano K, Kato T. Short-term efficacy evaluation of chronic pulmonary aspergillosis treated with micafangin and maintenance therapy of itraconazole. Nihon Kokyuki Gakkai Zasshi 2009; 47: 985-90.
22. Felton TW, Baxter C, Moore CB, Roberts SA, Hope WW, Denning DW. Efficacy and safety of posaconazole for chronic pulmonary aspergillosis. Clin Infect Dis 2010; 51: 1383-91.
23. Kohno S, Izumikawa K, Ogawa K et al. Intravenous micafungin versus voriconazole for chronic pulmonary aspergillosis: a multicenter trial in Japan. J Infect 2010; 61: 410-8.
24. Nam HS, Jeon K, Um SW et al. Clinical characteristics and treatment outcomes of chronic necrotizing pulmonary aspergillosis: a review of 43 cases. Int J Infect Dis 2010; 14: e479-82.
25. Kohno S, Izumikawa K, Kakeya H et al. Clinical efficacy and safety of micafungin in Japanese patients with chronic pulmonary aspergillosis: a prospective observational study. Med Mycol 2011; 49: 688-93.
26. Tomioka H, Kaneda T, Kida Y et al. An open, noncomparative multicenter study of the efficacy and safety of itraconazole injections and high dose capsules in chronic pulmonary aspergillosis. Kansenshogaku Zasshi 2011; 85: 644-51.
27. Cadranel J, Philippe B, Hennequin C et al. Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial. Eur J Clin Microbiol Infect Dis 2012; 31: 3231-9.
28. Fujita M, Tao Y, Kajiki A et al. The clinical efficacy and safety of micafungin-itraconazole combination therapy in patients with pulmonary aspergilloma. J Infect Chemother 2012; 18: 668-74.
29. Saito T, Fujiuchi S, Tao Y et al. Efficacy and safety of voriconazole in the treatment of chronic pulmonary aspergillosis: experience in Japan. Infection 2012; 40: 661-7.
30. Yoshida K, Kurashima A, Kamei K et al. Efficacy and safety of short- and long-term treatment of itraconazole on chronic necrotizing pulmonary aspergillosis in multicenter study. J Infect Chemother 2012; 18: 378-85.
31. Pratap H, Dewan RK, Singh L, Gill S, Vaddadi S. Surgical treatment of pulmonary aspergilloma: a series of 72 cases. Indian J Chest Dis Allied Sci 2007; 49: 23-27.
32. Akbari JG, Varma PK, Neema PK, Menon MU, Neelakandhan KS. Clinical profile and surgical outcome for pulmonary aspergilloma: a single center experience. Ann Thorac Surg 2005; 80: 1067-72.